TOLTERODINE: SUPERIOR TOLERABILITY THAN AND COMPARABLE EFFICACY TO OXYBUTYNIN IN INDIVIDUALS 50 YEARS OLD OR OLDER WITH OVERACTIVE BLADDER: A RANDOMIZED CONTROLLED TRIAL
- 1 May 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (6) , 1452-1456
- https://doi.org/10.1097/00005392-200105000-00013
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Efficacy and safety of tolterodine in patients with detrusor instability: a dose‐ranging studyBritish Journal of Urology, 1998
- The overactive bladder: Pharmacologic basis of drug treatmentUrology, 1997
- A new questionnaire to assess the quality of life of urinary incontinent womenBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Tolterodine – a new bladder-selective antimuscarinic agentEuropean Journal of Pharmacology, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- A Review of the Quality-of-Life Aspects of Urinary Urge IncontinencePharmacoEconomics, 1996
- OxybutyninDrugs & Aging, 1995
- Randomized, Double-Blind, Multicenter Trial on Treatment of Frequency, Urgency and Incontinence Related to Detrusor Hyperactivity: Oxybutynin versus Propantheline versus PlaceboJournal of Urology, 1991
- GENUINE STRESS INCONTINENCE AND DETRUSOR INSTABILITY—A REVIEW OF 200 PATIENTSBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Urinary Incontinence: Prevalence and NeedsBritish Journal of Urology, 1979